about
Folliculin interacts with p0071 (plakophilin-4) and deficiency is associated with disordered RhoA signalling, epithelial polarization and cytokinesisMolecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin geneParafibromin inhibits cancer cell growth and causes G1 phase arrestA putative human zinc-finger gene (ZFPL1) on 11q13, highly conserved in the mouse and expressed in exocrine pancreas. The European Consortium on MEN 1Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinomaFamilial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3-14Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP)Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implicationsHRPT2 mutations are associated with malignancy in sporadic parathyroid tumoursAbscisic acid perception and signaling: structural mechanisms and applicationsThe t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomasAltered expression of members of the IGF-axis in clear cell renal cell carcinomaIdentification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinomaCancer: biology and therapeutics--a tribute to George Vande WoudeDefinition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on Men1, (GENEM 1; Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1)The phospholipase C beta 3 gene located in the MEN1 region shows loss of expression in endocrine tumoursCharacterization of the mouse Men1 gene and its expression during developmentFunctional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding proteinExpression and chromosomal localization of the Requiem geneDeficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasiaCystic renal neoplasia following conditional inactivation of apc in mouse renal tubular epitheliumFacilitating a culture of responsible and effective sharing of cancer genome dataDefinition of the MinimalMEN1Candidate Area Based on a 5-Mb Integrated Map of Proximal 11q13Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains.Patterns of somatic mutation in human cancer genomesSystematic sequencing of renal carcinoma reveals inactivation of histone modifying genesGenomic profiling reveals mutational landscape in parathyroid carcinomasMutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance.Linkage analysis of candidate regions in Swedish nonsyndromic cleft lip with or without cleft palate families.Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles.Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma.Gene expression profiling of renal medullary carcinoma: potential clinical relevance.Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response.A comparison study reveals important features of agreement and disagreement between summarized DNA and RNA data obtained from renal cell carcinoma.Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphomaGene profiling suggests a common evolution of bladder cancer subtypesGenetic studies of thymic carcinoids in multiple endocrine neoplasia type 1Transient bilateral abducens neuropathy with post-tetanic facilitation and acute hypokalemia associated with oxaliplatin: a case report
P50
Q24298493-D6B4AFB8-842F-4D2B-BB08-CFF094AFA140Q24300102-47F1F146-3866-49BE-B7E3-A3015A712B5AQ24304063-36BD1381-5259-4110-BEB7-19BC9FBF2886Q24312735-5BB8BCDC-1B5B-40DE-8EA5-613688AEF494Q24337664-540D080C-9598-4FF7-B5AE-8801B68103FFQ24655804-CE84ECFD-5714-4746-8235-8711AFD51383Q24675703-557AA46C-A2E7-4A43-A244-0C9EC08F7C62Q24675796-75A5C198-259C-42F0-83A6-7B375007BAA0Q24676397-EB5D5A81-837B-4513-BB02-EFA4986E1AA5Q26822490-5913C3C8-EB25-43DE-B80D-5A54DE102C78Q28190533-F58E7381-A0C3-43AC-8E8C-9616417B0389Q28238701-06F1ADB2-95AE-4AB2-8B38-D190F25E3E3EQ28243243-61048360-BC9A-46D1-8464-9A1D92BCC033Q28254125-BA94B3CD-F9C0-40A9-B0FC-2919297FC1ABQ28290190-E40A597E-4D7F-4445-92C4-33332CA5CBB2Q28297875-CC155B76-FCD3-431F-82E2-D50D90692DBFQ28306877-B47B4056-2705-4EC5-9C88-BF796A8F90ADQ28505998-3E2D84AB-4D5C-4410-83B7-3C1D43635FA4Q28574570-7B468FE6-3A56-42AF-80D1-2194E0466A0CQ28587587-6131FFC2-2D45-4B5C-8E32-0A430A7EA2B9Q28587662-F6DA6BDF-6B26-4BD2-801C-5F1634471F2CQ28588368-834EFD79-41D8-4A85-8340-D6185EA082B1Q28597289-DEB3123F-C740-4163-82DA-7EA561E79D35Q29303492-92A24068-FEE1-4D9C-90AE-6FF02D7AB1A3Q29465803-4EC1F1C6-3DFA-40DD-8472-04774A8BF9ABQ29547841-A983B7B6-5719-493D-B0F0-CED3D3D507F3Q29615757-E7B85B54-15E9-4CE7-8107-2E8A0967BB3DQ30360213-1BBDBE2C-E971-411F-819C-DE012BAB1D2FQ30665308-295D7108-05F1-4789-801B-F4C471C98D75Q30888698-E1C1281D-F734-47FA-9AAE-71E77BC97174Q30939032-27A42899-7A57-4C99-A9BA-B55279223D94Q31108141-1AEF2B9E-1B2B-4983-BA4E-7709E1CC09B5Q33198627-C63B3654-A467-4860-B1B2-A8901B67D853Q33367131-9F2C5819-3ED8-4F7A-8E76-4F68DB6B3273Q33369311-9391E9E4-36CA-4CE0-854B-C87F9DA4AE25Q33511579-D4618A78-8509-4CD2-B7C1-0477D6B040EDQ33585243-F4C74833-17C2-4F82-82FF-AA65BCFF235CQ33589389-10AC9F89-C40F-48E6-AC3E-DA4B21EDB54CQ33673648-7BE484C0-B275-44C6-B603-FF207C0FEA33Q33683346-B79F4442-4C62-49E3-AC06-69350ABE0B9D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bin Tean Teh
@ast
Bin Tean Teh
@en
Bin Tean Teh
@es
Bin Tean Teh
@nl
Bin Tean Teh
@sl
type
label
Bin Tean Teh
@ast
Bin Tean Teh
@en
Bin Tean Teh
@es
Bin Tean Teh
@nl
Bin Tean Teh
@sl
prefLabel
Bin Tean Teh
@ast
Bin Tean Teh
@en
Bin Tean Teh
@es
Bin Tean Teh
@nl
Bin Tean Teh
@sl
P106
P1153
35393732200
P31
P496
0000-0003-1514-1124
P569
2000-01-01T00:00:00Z